For decades our public health agencies have insisted that current antibody testing and short courses of antibiotics for Lyme disease are adequate.
This view now needs to be discarded.
At the Dr. Paul Duray Research Fellowship Endowment Inc., pathologist Alan MacDonald MD, FCAP, FASCP, has been using highly specific Molecular Beacon DNA probes to in-vestigate the role of Borrelia in neurological diseases. The results have been no less than astonishing.
Using the technique of Fluorescent in situ hybridization (FISH), Borrelia biofilms (both Borrelia burgorferi and relapsing-fever type—miyamotoi) have been repeatedly detected in antibody-negative patients, as well as in patients treated with antibiotics.
In May 2016, the Duray foundation discovered that Borrelia endosymbionts dwell inside parasitic nematode worms which invade brain tissue, trampling neurons, and leaving a trail of destruction in their wake.
Endosymbionts live in harmony with their nematode host, but cause devastation once released into the brain.
(Left: Parasitic nematodes in tissue from brain tumor Glioblastoma multiforme (GBM) fluoresce, revealing the DNA of Borrelia endosymbionts. Copyright Dr. Alan MacDonald.)
In 2015, Dr. MacDonald identified Borrelia biofilms in 1000 consecutive amyloid plaques from five different autopsy Alzheimer brain tissue specimens. The plaques are a hallmark of this disease, which affects tens of millions worldwide.
While mainstream medical opinion believes that aberrant beta-amyloid protein and/or tau protein cause dementia, the micrographs tell a different story.
Alzheimer brain plaques stained for beta-amyloid stain IDENTICALLY when the DNA fluo-rescent probes for Borrelia are applied: the entire plaque appears to be filled with Borre-lia biofilm!